Please Wait...

Randomization & Trial Supply Management

Bioclinica offers the industry's only purpose-built, end-to-end, configurable randomization and trial supply management software platform. The flexible, intelligent RTSM platform combines the latest release of Bioclinica's Trident Agile IRT and the advanced Optimizer clinical supply forecasting and management software to significantly cut time, effort and cost for even the most complex global trials.

Bioclinica Agile RTSM

Run and compare different supply scenarios against trial objectives (e.g. schedule, cost, feasibility) for the optimum supply strategy

Accurately assess drug demand at study and program level; provide finished goods to API

Build, implement, test and deploy protocols in as little as two weeks with an integrated supply strategy

Accomplish fast, accurate patient randomization aligned with protocol

Get the right drugs to the right sites and patients at the right time with integrated, optimized RTSM

Identify and adjust enrollment and supply needs based on actuals

Reduce waste and destruction and reconciliation time, effort and cost with continually updated supply plans

Achieve faster database lock, lower cost and effort, yet higher quality data with continual optimization

See Bioclinica’s agile approach to IRT development…

With Bioclinica’s Agile RTSM platform, our customers are building, implementing, testing and deploying new protocols in as little as two weeks, reducing drug waste and study costs by millions of dollars and identifying changing trial conditions months in advance, lowering the risk to patients and studies.

THE AGILE APPROACH TO BIOCLINICA'S TRIDENT IRT

TRIDENT IRT

The leading end-to-end product and technology solution for sponsors and CROs.
LEARN MORE

OPTIMIZER

Powerful forecasting and demand-planning technology to manage global logistics of the clinical supply chain.
LEARN MORE

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is organized into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging & Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Molecular Marker Laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

"Mud run" 1 obstacle in vaccine trials w elderly. Here R 5 more & how to conquer by Dr. Craig Curtis… https://t.co/vIk4B2Howd
bioclinica (2 hours ago)
What's new in tech for ICH E6 R2 reqs for quality and #RBM? https://t.co/xsmNm8d35o #Pharma
bioclinica (5 hours ago)
Vaccine clinical trials: Boost senior participation following simple advice from Dr. Craig Curtis… https://t.co/OuTKyu0DPT
bioclinica (6 hours ago)
RT @ElisendaGendra: Decision on #EMA Relocation Set for November, Council Agrees on Bidding Procedure via @RAPSorg https://t.co/a42Eszg81o…
bioclinica (Yesterday)
@Xtalks Looking forward to tomorrow's webinar on site payments!
bioclinica (Yesterday)
Conducting Lymphoma ClinicalTrials? Lugano 2014 criteria for assessing FDG-PET/CT. An operational appch https://t.co/x5bdpI8jUI
bioclinica (Yesterday)

Latest Blogs: